ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
10.96
-0.01 (-0.09%)
Nov 20, 2024, 4:00 PM EST - Market closed
ClearPoint Neuro Revenue
ClearPoint Neuro had revenue of $8.12M in the quarter ending September 30, 2024, with 40.96% growth. This brings the company's revenue in the last twelve months to $30.43M, up 36.34% year-over-year. In the year 2023, ClearPoint Neuro had annual revenue of $23.96M with 16.56% growth.
Revenue (ttm)
$30.43M
Revenue Growth
+36.34%
P/S Ratio
9.47
Revenue / Employee
$284,383
Employees
107
Market Cap
302.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
Dec 31, 2019 | 11.22M | 3.86M | 52.54% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sage Therapeutics | 106.40M |
C4 Therapeutics | 33.67M |
Nyxoah | 5.67M |
Immutep | 2.56M |
Atai Life Sciences | 331.00K |
Lyell Immunopharma | 63.00K |
CLPT News
- 7 days ago - ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - Accesswire
- 10 days ago - ClearPoint Neuro: Near-Term Volatility Is No Concern - Seeking Alpha
- 13 days ago - ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - ClearPoint Neuro Reports Third Quarter 2024 Results - Accesswire
- 20 days ago - ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - Accesswire
- 4 weeks ago - ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - GlobeNewsWire
- 3 months ago - ClearPoint Neuro Announces Early Repayment of $10 Million Note - GlobeNewsWire
- 3 months ago - ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade) - Seeking Alpha